InvestorWire NewsRoom

InvestorNewsBreaks

NewsBreak Category: Cannabis
Monday Mar 18, 2024 - 11:08 am

InvestorNewsBreaks – BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) Announces Closing of $7M Underwritten Public Offering

BYND Cannasoft (NASDAQ: BCAN) (CSE: BYND), an Israeli-based integrated software and cannabis company, recently announced the closing of a firm commitment underwritten public offering with gross proceeds to the company of approximately $7.0 million. BYND Cannasoft expects to use the net proceeds from the offering for general corporate purposes and working capital. In addition, the company has granted Aegis Capital Corp. a 45-day option to…

Continue Reading

Friday Mar 15, 2024 - 12:11 pm

InvestorNewsBreaks – The Cannabis Place Opens Its New York City Flagship State-Licensed Dispensary in Middle Village Area

The Cannabis Place, a licensed adult-use dispensary operator in New York and New Jersey, is reporting the grand opening of its New York City flagship licensed dispensary. The location at 74-03 Metropolitan Avenue, Middle Village in Queens, will open its doors on Saturday, March 16, at 4.20 p.m. ET. “We picked this weekend to open because it’s symbolic in many ways. By opening our state-licensed…

Continue Reading

Thursday Mar 14, 2024 - 3:17 pm

InvestorNewsBreaks – Software Effective Solutions Corp. (SFWJ) Moving to Become World’s Premier Resource for High-Quality Pharmaceutical Products

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) has established five companies focused on pharmaceutical cannabis production, managing processes for plant-to-patient operations, and irrigation and greenhouse technology. “A global infrastructure and holding company in the cannabis industry, MedCana is on a mission to become the world’s premier resource for pharmaceutical cannabis products,” reads a recent article that discusses the burgeoning global medical marijuana market and the…

Continue Reading

Thursday Mar 14, 2024 - 12:47 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has appointed a new chief financial officer. The company announced that, effective immediately, Nelson Cabatuan, CPA, will serve in the position, which also entails being a member of Lexaria’s executive leadership team. Cabatuan brings more than 15 years of corporate finance and operations experience in the life sciences industry. Most recently, he served as…

Continue Reading

Tuesday Mar 12, 2024 - 1:09 pm

InvestorNewsBreaks — Zoned Properties Inc. (ZDPY) Chooses IBN as Corporate Communications Partner

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company focused on acquiring value-add real estate within the regulated cannabis industry, is partnering with IBN, a multifaceted financial news and publishing company for private and public entities. According to the announcement, IBN will assist Zoned Properties with its corporate communications initiatives and help strengthen awareness of the company. Zoned Properties is focused on innovating in the…

Continue Reading

Friday Mar 08, 2024 - 2:33 pm

InvestorNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) Subsidiary Tapping into Fast-Growing Opportunity

Astrotech (NASDAQ: ASTC), a science and technology company focused on commercializing its innovative platform mass spectrometry technology through its wholly owned subsidiaries, recently released financial results for Q2 2024. “The company recorded a 512% jump in its year-to-date (‘YTD’) revenue to $1,540,000 from $301,000 in the comparative period a year before. Astrotech attributed this growth primarily to two significant purchase orders for the TRACER 1000(TM)…

Continue Reading

Thursday Mar 07, 2024 - 12:23 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO for Second DehydraTECH-Powered GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced it has hired a contract research organization (“CRO”) to perform the company’s second DehydraTECH-powered glucagon-like peptide 1 (“GLP-1”) human pilot study #2. According to the announcement, the study will be a randomized, crossover, placebo-controlled investigation that will compare three formulations, each at a 7 mg semaglutide dose: a positive control Rybelsus(R)…

Continue Reading

Wednesday Mar 06, 2024 - 12:44 pm

InvestorNewsBreaks – Software Effective Solutions Corp. (SFWJ) Expands Portfolio, Marking Major Step Toward World-Leading Integration

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) today announced the successful acquisition of two additional companies, expanding its portfolio to nine innovative enterprises. According to the announcement, the strategic expansion includes a company with a critical cannabis genetics license and another with comprehensive licenses to produce, process and export cannabis products. “These acquisitions represent a monumental step towards our vision of becoming a world-leading integrated…

Continue Reading

Tuesday Mar 05, 2024 - 2:00 pm

InvestorNewsBreaks – Software Effective Solutions Corp. (SFWJ) Ideally Poised Amid Growing Evidence of Cannabis’ Benefits and Safety

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a global infrastructure and holding company in the cannabis industry, is paying close attention to growing data showing the power of cannabis. “One recent study, conducted by postdoctoral research fellow Thomas Arkell, a PhD at Swinburne University of Technology in Melbourne, Australia, suggests that medical cannabis treatment may be associated with improvements in health-related quality of life among…

Continue Reading

Tuesday Mar 05, 2024 - 12:23 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) to Commence Diabetes and Weight Loss Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced details for an eight-week animal study, WEIGHT-A24-1, to examine diabetes and weight loss effects of DehydraTECH-processed glucagon-like peptide 1 (“GLP-1”) drugs and DehydraTECH-processed cannabidiol, alone and in combination. The contract for the study was awarded to a third-party, Health Canada-licensed research laboratory. Manufacturing of the compositions for the first eight of…

Continue Reading

Tuesday Mar 05, 2024 - 10:20 am

InvestorNewsBreaks – Zoned Properties Inc. (ZDPY) Marks Pivotal Step in Scaling D2C Real Estate Portfolio

Zoned Properties (OTCQB: ZDPY), a technology driven property investment company for emerging and highly regulated industries, including legalized cannabis, today announced that it has listed its cultivation property in Chino Valley, Arizona (the “Chino Valley Property”) for sale at a purchase price of $16 million. The potential transaction marks a significant development in the company’s strategic real estate portfolio optimization. “As part of our ongoing…

Continue Reading

Monday Mar 04, 2024 - 12:03 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Weight-Loss Results in Animal Study, Begins Eight-Week Follow-Up Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting glucose reduction and weight-loss results in a testing of its wholly owned and patented DehydraTECH-CBD formulation. According to the announcement, when administered to rodents in an eight-week study, DehydraTech-CBD resulted in weight loss of 7% and a reduction of 19.9% (p<0.05) in blood glucose. As a result, Lexaria has now signed contracts to begin a…

Continue Reading

Friday Mar 01, 2024 - 3:21 pm

InvestorNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) Breakthrough TRACER 1000(TM) Designed to Outperform Currently Used IMS Detectors

Astrotech (NASDAQ: ASTC) is a mass spectrometry company that, through its wholly owned subsidiary 1st Detect, has developed and rolled out the breakthrough TRACER 1000(TM) Explosive Trace Detector (“ETD”). “The world’s first mass spectrometry-based ETD certified by the European Civil Aviation Conference (‘ECAC’), the TRACER 1000(TM) is designed to outperform the ETDs currently used at aviation checkpoints as well as borders, cargo facilities and other…

Continue Reading

Friday Mar 01, 2024 - 11:52 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Commence HYPER-H23-1 Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that the U.S. Food and Drug Administration (“FDA”) has confirmed the effectiveness of the company’s investigational new drug (“IND”) application thereby clearing Lexaria to conduct its planned U.S. Phase 1b hypertension clinical trial HYPER-H23-1 utilizing DehydraTECH-CBD. According to the announcement, the company is pleased to have complied with the FDA’s rules…

Continue Reading

Thursday Feb 29, 2024 - 1:25 pm

InvestorNewsBreaks — Alternative Products Expo Announces Largest Event for Counterculture, Vape Industries

Alternative Products Expo (Alt Pro Expo) has schedule an upcoming expo, slated for March 14–16, 2024, in Miami. Presented by ZJ Events, Alt Pro Expo’s Miami Expo 2024 will be an in-person event designed to be the world’s largest and most comprehensive event for the counterculture and vape industries. The event agenda features hundreds of top manufacturers, buyers, suppliers, innovators, vendors, researchers, aspiring entrepreneurs and seasoned…

Continue Reading

Thursday Feb 29, 2024 - 12:35 pm

InvestorNewsBreaks – Zoned Properties Inc. (ZDPY) Moves to Grow Investment Portfolio with Strategic Acquisition, Lease Agreement for Arizona-Based Property

Zoned Properties (OTCQB: ZDPY), a leading real estate development firm for emerging and highly regulated industries, including legalized cannabis, today announced its receipt of final cannabis approvals related to an investment property in Surprise, Arizona. The company is under contract to acquire the property upon completion of initial site work by the selling developer. In addition, Zoned Properties has entered into a long-term, absolute-net lease…

Continue Reading

Wednesday Feb 28, 2024 - 11:46 am

InvestorNewsBreaks – Software Effective Solutions Corp.’s (SFWJ) Columbia-Based Subsidiary Names Agri-Tech Leader as Sales Director

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) today announced that Eko2o S.A.S., a majority controlled subsidiary of MedCana in Colombia and a leading provider of greenhouse infrastructure and agricultural technology, has appointed Paula Restrepo as its new sales director. With a career spanning over nine years as a technical representative for a prominent technology company in the Colombian flower industry, Restrepo brings a wealth of…

Continue Reading

Thursday Feb 22, 2024 - 2:09 pm

InvestorNewsBreaks — Marigold PR Announces Upcoming Radicle Femmes Event Focused on Women in Cannabis

Marigold PR, an award-winning public relations agency to the North American cannabis industry, announced that it is hosting the first-ever Radicle Femmes event. According to the announcement, Radicle Femmes is designed to be Canada’s largest networking event celebrating women in cannabis. The premiere event is slated for March 8, 2024, which is International Women’s Day; it will be held in Toronto in collaboration with several…

Continue Reading

Wednesday Feb 21, 2024 - 3:11 pm

InvestorNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) Subsidiary Bringing ‘Game Changer’ Technology in AgLAB MVP

Astrotech’s (NASDAQ: ASTC) subsidiary AgLAB, Inc. has breakthrough mass spectrometry technology in its AgLAB 1000-D2 mass spectrometer and the Maximum Value Process(TM) testing method (“AgLAB MVP”). “AgLAB MVP is designed to improve yields and bottom-line profits for hemp (‘CBD’) and cannabis (‘THC’) producers of CBD-THC oils by up to 30%. Large-scale CBD and THC oil processors use molecular distillation systems (‘MDS’) to produce the valuable…

Continue Reading

Wednesday Feb 21, 2024 - 11:37 am

InvestorNewsBreaks – Software Effective Solutions Corp. (SFWJ) to Expand Portfolio with Strategic Acquisition

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a leading holding company in the cannabis industry, today announced final stages of negotiations to acquire its sixth cannabis company in Colombia. The acquisition is extremely significant because of the company’s cannabis genetics license, which MedCana believes will revolutionize its potential to create and register unique cannabis genetic varieties for production and commercialization. “The addition of this new…

Continue Reading

Tuesday Feb 20, 2024 - 11:26 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Closing of $3.6M Registered Direct Offering

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has closed on a registered direct offering. The offering included the purchase and sale of 1,558,443 shares of common stock (or common stock equivalents in lieu thereof) offered at $2.31 per share. The company also noted that, in a concurrent private placement, it issued unregistered warrants to purchase up to 1,558,443 shares of common…

Continue Reading

Wednesday Feb 14, 2024 - 10:57 am

InvestorNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ), Subsidiary Ink Multiyear Deal with Danziger Colombia

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) and its majority-controlled subsidiary, Eko2o Environmental Solutions S.A.S., have signed a multiyear contract with Danziger Colombia. According to the announcement, the agreement outlines plans for Colombia-based Eko2o, a leading provider of greenhouse infrastructure and agricultural technology, to provide greenhouse infrastructure services, irrigation products and technology to Danziger’s flower operations in Colombia. The company anticipates the agreement, which…

Continue Reading

Wednesday Feb 14, 2024 - 9:48 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Numbers for Q2 2024, Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on its financial results for Q2 2024, the period ended Dec. 31, 2023. The company also provided a corporate update, including plans to advance two preclinical programs in Alzheimer's and age-related macular degeneration. Highlights of the report included that the company closed the 2023…

Continue Reading

Tuesday Feb 13, 2024 - 1:52 pm

InvestorNewsBreaks – IBN’s CNW to Elevate Visibility for ZJ Events in 2024

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 60+ brands within IBN (“InvestorBrandNetwork”), has announced its renewed partnership as the official newswire for ZJ Events in 2024. ZJ Events, an innovative organizer hosting multiple trade shows across the USA and South America every year, is set to deliver a captivating 2024 event series, featuring the BizCann Expo and Alternative…

Continue Reading

Tuesday Feb 13, 2024 - 9:39 am

InvestorNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Releases Q2 2024 Financial Report

Astrotech (NASDAQ: ASTC), an innovative science and technology company, is releasing its financial results for Q2 2024, the period ended Dec. 31, 2023. Highlights of the report include a 512% increase in year-to-date revenue, which reached $1,540,000 compared to $301,000 in the same period in 2023; a strong consolidated balance sheet with $37 million in cash and liquid investments; and a year-to-date FY 2024 gross margin…

Continue Reading

Monday Feb 12, 2024 - 3:34 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Patented DehydraTECH(TM) Improves Delivery of GLP-1 Drug to Bloodstream

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, announced the final results from its completed human Pilot Study #1 that sought to evaluate the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). “Most notable from its pilot study was the improved delivery of semaglutide to…

Continue Reading

Monday Feb 12, 2024 - 3:00 pm

InvestorNewsBreaks – Software Effective Solutions Corp. (SFWJ) Committed to Building Capabilities to Provide Pharmaceutical-Grade Cannabis Extracts to the World

Software Effective Solutions (OTC: SFWJ) is among companies in the cannabis space paying close attention to the mounting calls for the rescheduling of cannabis to a Schedule III from a Schedule I substance per the Controlled Substances Act (“CSA”). “The call for cannabis rescheduling on the CSA list is not new, but it has gained momentum since the U.S. Department of Health and Human Services…

Continue Reading

Friday Feb 09, 2024 - 11:48 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officer

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, has announced the appointment of Netta Jagpal, CPA, CA, as the newest member of its executive team; Jagpal will serve as the company chief financial officer and corporate secretary, effective Feb. 20, 2024. Jagpal has garnered more than two decades of experience in financial leadership roles,…

Continue Reading

Wednesday Feb 07, 2024 - 1:01 pm

InvestorNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Introducing Breakthrough Technology, Potential ‘Game Changer’ for the Cannabinoid Industry

Astrotech (NASDAQ: ASTC) is an instrumentation company that is focused on commercializing its proprietary ATi Mass Spectrometer Technology(TM). Its subsidiary, AgLAB Inc., has breakthrough mass spectrometry technology in its AgLAB-1000-D2 mass spectrometer, a ruggedized factory floor analytical instrument designed to quickly and easily analyze complex chemical compounds found in organic plant materials, and the Maximum Value Process(TM) testing method (“AgLAB MVP”). “AgLAB MVP is designed…

Continue Reading

Tuesday Jan 30, 2024 - 11:41 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Submission of IND for Planned Phase 1b Hypertension Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has submitted its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”). The application covers HYPER-H23-1, the company’s upcoming planned U.S. phase 1b hypertension clinical trial of DehydraTECH-CBD. According to the announcement, the company had a successful pre-IND meeting with FDA officials. Following the guidance provided in that meeting…

Continue Reading

Friday Jan 26, 2024 - 2:25 pm

InvestorNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) Pro-Control-1000(TM) Line Poised to Help Manufacturers Improve Profits, Yields

Astrotech (NASDAQ: ASTC ), an instrumentation company focused on commercializing its proprietary ATi Mass Spectrometer Technology(TM) that is now used in airports and agriculture applications throughout the world, continues to expand its technology into new markets. “Astrotech has announced the introduction of its newest Pro-Control-1000(TM) product line of instrumentation designed to improve chemical manufacturing efficiencies. Astrotech is also announcing the creation of its newest wholly…

Continue Reading

Thursday Jan 25, 2024 - 2:01 pm

InvestorNewsBreaks — Boston Hemp Inc. Unveils New Product Designed to Redefine Cannabis Consumption

Boston Hemp, a pioneer in the cannabis industry, has launched its latest product: THCa Crumble Extract. According to the announcement, the groundbreaking new product showcases the company's commitment to providing consumers with high-quality, cutting-edge solutions for a diverse range of cannabis experiences. A carefully crafted concentrate, THCa Crumble Extract is designed to “harness” the power of tetrahydrocannabinolic acid (“THCa”) and provides the user with a…

Continue Reading

Wednesday Jan 24, 2024 - 11:14 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Shares Company Update in Annual Shareholder Letter

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has released a shareholder letter from CEO Chris Bunka. In the letter, Bunka notes that near the end of 2023, 446 companies on the NASDAQ were trading under $1 and at risk of being delisted compared to almost none in 2021. Bunka stated that “it was a tough year for microcap companies, which are…

Continue Reading

Friday Jan 19, 2024 - 9:56 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO to Present at January Water Tower Research Fireside Chat

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, announced that CEO Eric A Adams will be participating in the upcoming Water Tower Research Fireside Chat Series. This month’s chat is scheduled to begin at 1 p.m. ET on Jan. 25, 2024. According to the announcement, topics discussed during the event will include an overview…

Continue Reading

Wednesday Jan 17, 2024 - 12:29 pm

InvestorNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Engages IBN for Corporate Communications Expertise

Astrotech (NASDAQ: ASTC) is an instrumentation company focused on commercializing its proprietary ATi Mass Spectrometer Technology(TM) that is now used in airports and agriculture applications around the world. The company today announced that it has selected IBN, a multifaceted financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. Astrotech continues to expand its ATi Mass Spectrometer Technology…

Continue Reading

Tuesday Jan 16, 2024 - 12:54 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today unveiled a comprehensive planned applied research program to thoroughly evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical companies. In a recent human pilot study with seven volunteers, Lexaria demonstrated superior pharmacokinetic (“PK”) oral delivery performance of the DehydraTECH-enhanced glucagon-like peptide-1 (“GLP-1”) drug…

Continue Reading

Tuesday Jan 16, 2024 - 12:22 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today outlined key accomplishments from 2023 and provided key strategic priorities for 2024. “In 2023, we experienced significant progress in both InMed’s pharmaceutical drug development and in BayMedica’s health and wellness initiatives. Our primary accomplishments throughout the year included a number of key milestones, such as…

Continue Reading

Friday Jan 12, 2024 - 2:07 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Grow Revenue and Commercial Opportunities Through Licensing

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is committed to providing healthier delivery methods of drugs and other active pharmaceutical ingredients (“APIs”) through its patented drug delivery technology, DehydraTECH(TM). “The company’s efforts have focused on several key segments, including hypertension, diabetes, antivirals, epilepsy, nicotine replacement, and more. This has been an ongoing process since 2016, with positive results achieved from…

Continue Reading

Wednesday Jan 10, 2024 - 3:09 pm

InvestorNewsBreaks – Why Astrotech Corporation (NASDAQ: ASTC) Is ‘One to Watch’

Astrotech (NASDAQ: ASTC ) is an instrumentation company that designs, manufactures and commercializes solutions. These include mass spectrometry, process controls, chemical detectors and medical disease detection. The company is headquartered in Austin, Texas, and owns four subsidiaries: Astrotech Technologies Inc., 1st Detect Corp., AgLAB Inc., and BreathTech Corp. “Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (‘ECAC’)…

Continue Reading

Tuesday Jan 09, 2024 - 11:24 am

InvestorNewsBreaks – Branded Legacy Inc. (BLEG) Acquires All In Extracts LLC

Branded Legacy (OTC: BLEG), (soon to be known as Royal Enterprises Inc.), a burgeoning company in the pharmaceutical biotechnology sector, today announced its strategic acquisition of All In Extracts, a pioneering entity focused on medicinal ethnobotany. The milestone deal amplifies Branded Legacy’s focus on innovation, expansion and collaborative growth within the biotech community. “As soon as I met with the All In team, I knew…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).